ALSO NOTED: UCB announces Crohn's data; CytRx cuts lab jobs; Modigene raises $15M; and much more...

> UCB announced today that new data presented at Digestive Disease Week 2007 demonstrated long-term response and remission in Crohn's disease patients treated with CIMZIA, the only Fc-free PEGylated, Fab' fragment anti-TNF. Release

> CytRx says it will cut almost all of its lab jobs at its Massachusetts facility as it relocates its lab to San Diego. Report

> Modigene announced the second and final closing of a private placement that raised $15 million overall. Release

> Protherics said that it believes it can gain FDA approval for Voraxaze by the end of 2009. Report

> Chutes & Ladders: Carlton E. Turner, Ph.D., D.Sc., announced his intention to retire from his position as president and CEO of Carrington Laboratories effective December 31, 2008. Release

And Finally...Macrophages - the scavenger cells of the body's immune system - are known as troublemakers for the role they play in obesity, but Stanford University School of Medicine researchers have found that the cells can also be saviors when it comes to metabolism. Release

Suggested Articles

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.

The role gives one of the driving forces behind Bristol Myers Squibb’s $74 billion takeover of Celgene the chance to help build biotechs.

The appointment gives Sino-American biotech Brii the experience of a man who helped Gilead launch eight drugs in China in quick succession.